SpyGlass Pharma, Inc. (SGP)
26.03
-0.39
(-1.48%)
USD |
NASDAQ |
Aug 31, 14:08
SpyGlass Pharma EPS Diluted (Quarterly) : -0.5939 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5939 |
| March 31, 2026 | -0.6934 |
| December 31, 2025 | -0.3756 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.2595 |
| March 31, 2025 | -3.957 |
| December 31, 2024 | -0.2632 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.86M |
| Total Expenses (Quarterly) | 19.86M |
| Enterprise Value | 651.10M |
| Earnings Yield | -7.39% |
| Normalized Earnings Yield | -7.385 |